In this study, we demonstrated that our LNPs not only prolong the blood half‐life of the cytokine IL‐10, but also enrich IL‐10 in tumor tissues which is essential for improving the efficacy of adoptive T cell therapy as well as immune checkpoint blockade drugs. Here, IL10 is linked to neoplasm.